Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	pancreatic polypeptide receptor activity	NPY1R NPY4R2 NPY4R	1.05e-06	4	129	3	GO:0001602
GeneOntologyMolecularFunction	neuropeptide Y receptor activity	NPY1R NPY4R2 NPY4R	4.18e-05	11	129	3	GO:0004983
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 DNAH9 DNAH11	2.00e-04	18	129	3	GO:0008569
Domain	NPY_rcpt	NPY1R NPY4R2 NPY4R	2.56e-05	9	128	3	IPR000611
Domain	NPY4_rcpt	NPY4R2 NPY4R	4.66e-05	2	128	2	IPR001933
Domain	PNT	ERG SPDEF GABPA	4.98e-05	11	128	3	PS51433
Domain	SAM_PNT	ERG SPDEF GABPA	4.98e-05	11	128	3	PF02198
Domain	-	MARS1 LARS1 DALRD3	4.98e-05	11	128	3	1.10.730.10
Domain	Pointed_dom	ERG SPDEF GABPA	4.98e-05	11	128	3	IPR003118
Domain	SAM_PNT	ERG SPDEF GABPA	4.98e-05	11	128	3	SM00251
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH9 DNAH11	1.08e-04	14	128	3	IPR024317
Domain	Dynein_HC_stalk	DNAH14 DNAH9 DNAH11	1.08e-04	14	128	3	IPR024743
Domain	MT	DNAH14 DNAH9 DNAH11	1.08e-04	14	128	3	PF12777
Domain	AAA_8	DNAH14 DNAH9 DNAH11	1.08e-04	14	128	3	PF12780
Domain	DHC_fam	DNAH14 DNAH9 DNAH11	1.35e-04	15	128	3	IPR026983
Domain	Dynein_heavy	DNAH14 DNAH9 DNAH11	1.35e-04	15	128	3	PF03028
Domain	Dynein_heavy_dom	DNAH14 DNAH9 DNAH11	1.35e-04	15	128	3	IPR004273
Domain	tRNAsynth_Ia_anticodon-bd	MARS1 LARS1 DALRD3	1.35e-04	15	128	3	IPR009080
Domain	-	BRIP1 MFHAS1 PEX1 NLRP1 FANCM OPA1 DNAH14 RAB38 PALS1 SHPRH COASY CDC6 PALS2 DNAH9 DNAH11	1.82e-04	746	128	15	3.40.50.300
Domain	P-loop_NTPase	BRIP1 MFHAS1 KIF1B PEX1 NLRP1 FANCM OPA1 DNAH14 RAB38 PALS1 SHPRH COASY CDC6 PALS2 DNAH9 DNAH11	2.26e-04	848	128	16	IPR027417
Domain	DCB_dom	MON2 ARFGEF3	2.77e-04	4	128	2	IPR032629
Domain	Sec7_C	MON2 ARFGEF3	2.77e-04	4	128	2	IPR015403
Domain	DUF1981	MON2 ARFGEF3	2.77e-04	4	128	2	PF09324
Domain	DCB	MON2 ARFGEF3	2.77e-04	4	128	2	PF16213
Domain	TMEM132D_N	TMEM132B TMEM132A	4.60e-04	5	128	2	PF15705
Domain	TMEM132D_C	TMEM132B TMEM132A	4.60e-04	5	128	2	PF15706
Domain	TMEM132_M	TMEM132B TMEM132A	4.60e-04	5	128	2	IPR031437
Domain	TMEM132_C	TMEM132B TMEM132A	4.60e-04	5	128	2	IPR031436
Domain	TMEM132_N	TMEM132B TMEM132A	4.60e-04	5	128	2	IPR031435
Domain	TMEM132	TMEM132B TMEM132A	4.60e-04	5	128	2	IPR026307
Domain	TMEM132	TMEM132B TMEM132A	4.60e-04	5	128	2	PF16070
Domain	ETS_DOMAIN_1	ERG SPDEF GABPA	9.09e-04	28	128	3	PS00345
Domain	ETS_DOMAIN_2	ERG SPDEF GABPA	9.09e-04	28	128	3	PS00346
Domain	Ets	ERG SPDEF GABPA	9.09e-04	28	128	3	PF00178
Domain	ETS	ERG SPDEF GABPA	9.09e-04	28	128	3	SM00413
Domain	Ets_dom	ERG SPDEF GABPA	9.09e-04	28	128	3	IPR000418
Domain	ETS_DOMAIN_3	ERG SPDEF GABPA	9.09e-04	28	128	3	PS50061
Domain	DHC_N1	DNAH9 DNAH11	1.27e-03	8	128	2	PF08385
Domain	VIT	ITIH4 PARP4	1.27e-03	8	128	2	PF08487
Domain	VIT	ITIH4 PARP4	1.27e-03	8	128	2	SM00609
Domain	Dynein_heavy_dom-1	DNAH9 DNAH11	1.27e-03	8	128	2	IPR013594
Domain	RuvA_2-like	FANCM SUPT6H	1.63e-03	9	128	2	IPR010994
Domain	L27_C	PALS1 PALS2	2.02e-03	10	128	2	IPR014775
Domain	L27	PALS1 PALS2	2.02e-03	10	128	2	PF02828
Domain	VIT	ITIH4 PARP4	2.02e-03	10	128	2	PS51468
Domain	VIT	ITIH4 PARP4	2.02e-03	10	128	2	IPR013694
Domain	HlyIII	PAQR5 PAQR6	2.46e-03	11	128	2	PF03006
Domain	AdipoR/HlyIII-related	PAQR5 PAQR6	2.46e-03	11	128	2	IPR004254
Domain	Rossmann-like_a/b/a_fold	MARS1 LARS1 COASY	3.18e-03	43	128	3	IPR014729
Domain	-	MARS1 LARS1 COASY	3.18e-03	43	128	3	3.40.50.620
Domain	L27	PALS1 PALS2	3.46e-03	13	128	2	SM00569
Domain	L27	PALS1 PALS2	3.46e-03	13	128	2	PS51022
Domain	L27_dom	PALS1 PALS2	3.46e-03	13	128	2	IPR004172
Domain	Dynein_heavy_dom-2	DNAH9 DNAH11	4.02e-03	14	128	2	IPR013602
Domain	DHC_N2	DNAH9 DNAH11	4.02e-03	14	128	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH9 DNAH11	4.02e-03	14	128	2	IPR011704
Domain	AAA_5	DNAH9 DNAH11	4.02e-03	14	128	2	PF07728
Domain	GRAM	TBC1D8 SBF1	5.25e-03	16	128	2	SM00568
Domain	Guanylate_kinase_CS	PALS1 PALS2	5.25e-03	16	128	2	IPR020590
Domain	VWF_type-D	KCP MUC4	5.25e-03	16	128	2	IPR001846
Domain	VWFD	KCP MUC4	5.25e-03	16	128	2	PS51233
Domain	VWD	KCP MUC4	5.25e-03	16	128	2	SM00216
Domain	VWD	KCP MUC4	5.25e-03	16	128	2	PF00094
Domain	-	ERG PPFIA1 SPDEF GABPA	6.10e-03	106	128	4	1.10.150.50
Domain	LRR_6	NLRP1 FBXL6 TLR3	6.36e-03	55	128	3	PF13516
Domain	aa-tRNA-synth_I_CS	MARS1 LARS1	6.64e-03	18	128	2	IPR001412
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 MFHAS1 INTS1 CBLC GEMIN5 GRID1 MED13L ZZEF1 RYR1 FOCAD PSME4 SBF1 PPP1R15B TMEM132A HERC1 SOWAHB EVI5L CBX2	1.70e-07	1105	130	18	35748872
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	MARS1 PPFIA1 TFIP11 SPG11 ALDH1L1 OPA1 STAT5A SHPRH ATM HERC1 PLOD1 MUC4	3.99e-07	497	130	12	36774506
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	SEC16B ERG NT5E NUP98 ALDH1L1 MED13L CFI OPA1 TMEM132A ALG8	5.47e-06	431	130	10	33660365
Pubmed	Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts.	ERG TMPRSS2	1.39e-05	2	130	2	18922926
Pubmed	Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	19147579
Pubmed	Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.	ERG TMPRSS2	1.39e-05	2	130	2	21743434
Pubmed	TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.	ERG TMPRSS2	1.39e-05	2	130	2	23701505
Pubmed	Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.	ERG TMPRSS2	1.39e-05	2	130	2	19584163
Pubmed	Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	34341114
Pubmed	Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.	ERG TMPRSS2	1.39e-05	2	130	2	26503111
Pubmed	Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts.	ERG TMPRSS2	1.39e-05	2	130	2	20068566
Pubmed	5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	23472063
Pubmed	Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	24195515
Pubmed	Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer.	ERG TMPRSS2	1.39e-05	2	130	2	27926866
Pubmed	The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer.	ERG TMPRSS2	1.39e-05	2	130	2	22076164
Pubmed	Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	18694509
Pubmed	TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate.	ERG TMPRSS2	1.39e-05	2	130	2	21802835
Pubmed	TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences.	ERG TMPRSS2	1.39e-05	2	130	2	28633309
Pubmed	TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	21394739
Pubmed	Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.	ERG TMPRSS2	1.39e-05	2	130	2	24292212
Pubmed	Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells.	ERG TMPRSS2	1.39e-05	2	130	2	23535644
Pubmed	Chemical shift and secondary structure conservation of the PNT/SAM domains from the ets family of transcription factors.	ERG GABPA	1.39e-05	2	130	2	12449421
Pubmed	The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.	ERG TMPRSS2	1.39e-05	2	130	2	21937078
Pubmed	TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	27377958
Pubmed	Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	23447416
Pubmed	TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	33141952
Pubmed	The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.	ERG TMPRSS2	1.39e-05	2	130	2	22736790
Pubmed	Cells Lacking PA200 Adapt to Mitochondrial Dysfunction by Enhancing Glycolysis via Distinct Opa1 Processing.	OPA1 PSME4	1.39e-05	2	130	2	33562813
Pubmed	A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	23352841
Pubmed	Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	16575875
Pubmed	Detection of TMPRSS2-ERG Fusion Transcript in Biopsy Specimen of Prostate Cancer Patients: A Single Centre Experience.	ERG TMPRSS2	1.39e-05	2	130	2	32573479
Pubmed	Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.	ERG TMPRSS2	1.39e-05	2	130	2	25852077
Pubmed	Theoretical study of the interactions between peptide tyrosine tyrosine [PYY (1-36)], a newly identified modulator in type 2 diabetes pathophysiology, with receptors NPY1R and NPY4R.	NPY1R NPY4R	1.39e-05	2	130	2	33782920
Pubmed	[Deguelin regulates cell cycle and nuclear pore complex protein Nup98 and Nup88 in U937 cells in vitro].	NUP88 NUP98	1.39e-05	2	130	2	17650673
Pubmed	TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells.	ERG TMPRSS2	1.39e-05	2	130	2	30718921
Pubmed	Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.	GDF9 CDC6	1.39e-05	2	130	2	23011157
Pubmed	Induced chromosomal proximity and gene fusions in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	19933109
Pubmed	TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.	ERG TMPRSS2	1.39e-05	2	130	2	19190343
Pubmed	TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate.	ERG TMPRSS2	1.39e-05	2	130	2	21040948
Pubmed	Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.	ERG TMPRSS2	1.39e-05	2	130	2	21677539
Pubmed	TMPRSS2-ERG fusion transcripts expression in patients referred for prostate biopsy: combining detection in urine and needle rinse material.	ERG TMPRSS2	1.39e-05	2	130	2	24997128
Pubmed	Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review.	ERG TMPRSS2	1.39e-05	2	130	2	26774207
Pubmed	[Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].	ERG TMPRSS2	1.39e-05	2	130	2	26978019
Pubmed	Disruption of the FG nucleoporin NUP98 causes selective changes in nuclear pore complex stoichiometry and function.	NUP88 NUP98	1.39e-05	2	130	2	11248054
Pubmed	Activation of SRC kinase and phosphorylation of signal transducer and activator of transcription-5 are required for decidual transformation of human endometrial stromal cells.	SRC STAT5A	1.39e-05	2	130	2	18063684
Pubmed	Molecular basis for the anchoring of proto-oncoprotein Nup98 to the cytoplasmic face of the nuclear pore complex.	NUP88 NUP98	1.39e-05	2	130	2	22480613
Pubmed	Detection of TMPRSS2-ERG fusion gene in benign prostatic hyperplasia.	ERG TMPRSS2	1.39e-05	2	130	2	24961351
Pubmed	Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.	ERG TMPRSS2	1.39e-05	2	130	2	33301988
Pubmed	TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	25015038
Pubmed	Activating SRC mutation in a subset of advanced human colon cancers.	SRC CBLC	1.39e-05	2	130	2	9988270
Pubmed	Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer.	ERG TMPRSS2	1.39e-05	2	130	2	25933120
Pubmed	Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.	ERG TMPRSS2	1.39e-05	2	130	2	27798103
Pubmed	Delineation of TMPRSS2-ERG splice variants in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	18676740
Pubmed	Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	29773553
Pubmed	Signaling networks in TMPRSS2-ERG positive prostate cancers: Do we need a Pied Piper or sharpshooter to deal with "at large" fused oncoprotein.	ERG TMPRSS2	1.39e-05	2	130	2	28364793
Pubmed	Persistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: preliminary results.	ERG TMPRSS2	1.39e-05	2	130	2	19494719
Pubmed	Intrafocal heterogeneity of ERG protein expression and gene fusion pattern in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	28845585
Pubmed	TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers.	ERG TMPRSS2	1.39e-05	2	130	2	21676887
Pubmed	The role of TMPRSS2:ERG in molecular stratification of PCa and its association with tumor aggressiveness: a study in Brazilian patients.	ERG TMPRSS2	1.39e-05	2	130	2	25007891
Pubmed	Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion.	ERG TMPRSS2	1.39e-05	2	130	2	19396154
Pubmed	The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	25728532
Pubmed	Inhibition of Src by direct interaction with protein phosphatase 2A.	SRC PTPA	1.39e-05	2	130	2	11576548
Pubmed	Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.	ERG TMPRSS2	1.39e-05	2	130	2	18519767
Pubmed	TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.	ERG TMPRSS2	1.39e-05	2	130	2	18519769
Pubmed	Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	18483239
Pubmed	Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.	ERG TMPRSS2	1.39e-05	2	130	2	16820092
Pubmed	Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.	ERG TMPRSS2	1.39e-05	2	130	2	32229180
Pubmed	Methylation determines the extracellular calcium sensitivity of the leak channel NALCN in hippocampal dentate granule cells.	NALCN PRMT7	1.39e-05	2	130	2	31601786
Pubmed	Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers.	ERG TMPRSS2	1.39e-05	2	130	2	17654723
Pubmed	Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	27276682
Pubmed	ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.	ERG TMPRSS2	1.39e-05	2	130	2	21499238
Pubmed	TMPRSS2-ERG gene fusion and clinicopathologic characteristics of Korean prostate cancer patients.	ERG TMPRSS2	1.39e-05	2	130	2	20800881
Pubmed	Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	22993300
Pubmed	TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort.	ERG TMPRSS2	1.39e-05	2	130	2	19029822
Pubmed	Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	18065961
Pubmed	TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.	ERG TMPRSS2	1.39e-05	2	130	2	19664128
Pubmed	Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry.	ERG TMPRSS2	1.39e-05	2	130	2	23850495
Pubmed	Retention of Interstitial Genes between TMPRSS2 and ERG Is Associated with Low-Risk Prostate Cancer.	ERG TMPRSS2	1.39e-05	2	130	2	29127096
Pubmed	Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer.	ERG TMPRSS2	1.39e-05	2	130	2	27144529
Pubmed	TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	27320318
Pubmed	TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.	ERG TMPRSS2	1.39e-05	2	130	2	24297949
Pubmed	TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.	ERG TMPRSS2	1.39e-05	2	130	2	25263440
Pubmed	In situ sequencing identifies TMPRSS2-ERG fusion transcripts, somatic point mutations and gene expression levels in prostate cancers.	ERG TMPRSS2	1.39e-05	2	130	2	24931216
Pubmed	Microdeletion and concurrent translocation associated with a complex TMPRSS2:ERG prostate cancer gene fusion.	ERG TMPRSS2	1.39e-05	2	130	2	17584912
Pubmed	Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer.	ERG TMPRSS2	1.39e-05	2	130	2	21584900
Pubmed	MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.	ERG MED13L MED23	1.42e-05	13	130	3	27570068
Pubmed	The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.	BRIP1 FANCM ATM	2.25e-05	15	130	3	19536649
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	MON2 ROCK2 KNTC1 MARS1 CTSC PPFIA1 KIF1B NUP88 LARS1 NUP98 GEMIN5 ZZEF1 PSME4 COASY HERC1 PLOD1 GABPA	3.13e-05	1455	130	17	22863883
Pubmed	Squamous Non-Small-Cell Lung Cancer Molecularly Reclassified as Transdifferentiated Prostate Cancer Due to Identification of TMPRSS2-ERG Translocation With SOX2 Amplification.	ERG TMPRSS2	4.15e-05	3	130	2	32840422
Pubmed	BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer.	ERG TMPRSS2	4.15e-05	3	130	2	29346775
Pubmed	Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort.	ERG TMPRSS2	4.15e-05	3	130	2	20118910
Pubmed	Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG.	ERG TMPRSS2	4.15e-05	3	130	2	24072184
Pubmed	The association of diabetes with risk of prostate cancer defined by clinical and molecular features.	ERG TMPRSS2	4.15e-05	3	130	2	32467600
Pubmed	Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.	ERG TMPRSS2	4.15e-05	3	130	2	17632455
Pubmed	Involvement of Src in the membrane skeletal complex, MPP6-4.1G, in Schmidt-Lanterman incisures of mouse myelinated nerve fibers in PNS.	SRC PALS2	4.15e-05	3	130	2	23306908
Pubmed	Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.	ERG TMPRSS2	4.15e-05	3	130	2	21731703
Pubmed	Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways.	SRC ATM	4.15e-05	3	130	2	30224064
Pubmed	The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation.	STAT5A ATM	4.15e-05	3	130	2	23593005
Pubmed	Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer.	ERG TMPRSS2	4.15e-05	3	130	2	20442300
Pubmed	Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers.	ERG TMPRSS2	4.15e-05	3	130	2	32150281
Interaction	GPR17 interactions	KNTC1 INTS1 TFIP11 SPG11 OPA1 ARFGEF3 ALG8 ATM CDC6 MED23 HEATR5B EVI5L	2.39e-07	283	127	12	int:GPR17
Interaction	BTNL9 interactions	MON2 KNTC1 PPFIA1 INTS1 TFIP11 RAB38 FOCAD TBC1D8 SBF1	6.44e-07	156	127	9	int:BTNL9
Interaction	NPTN interactions	MON2 KNTC1 INTS1 GEMIN5 SPG11 OPA1 RAB38 FOCAD ARFGEF3 ATM HEATR5B	1.53e-06	278	127	11	int:NPTN
Interaction	NPY2R interactions	MON2 INTS1 OPA1 ARFGEF3 ATM EVI5L	3.71e-06	66	127	6	int:NPY2R
Interaction	GPR45 interactions	MON2 KNTC1 INTS1 PEX1 SPG11 OPA1 RAB38 TBC1D8 ATM EVI5L	2.07e-05	300	127	10	int:GPR45
Interaction	COMTD1 interactions	KNTC1 MARS1 INTS1 NUP98 GEMIN5 TFIP11 TBC1D8 TMPRSS2	4.00e-05	200	127	8	int:COMTD1
Interaction	P2RY10 interactions	MON2 INTS1 OPA1 ARFGEF3 ATM EVI5L	5.67e-05	106	127	6	int:P2RY10
Cytoband	17p13.2	NUP88 NLRP1 ZZEF1 INCA1	1.87e-05	55	130	4	17p13.2
GeneFamily	Dyneins, axonemal	DNAH14 DNAH9 DNAH11	8.78e-05	17	94	3	536
GeneFamily	ETS transcription factor family	ERG SPDEF GABPA	4.06e-04	28	94	3	534
GeneFamily	Neuropeptide receptors	NPY1R NPY4R	1.17e-03	10	94	2	854
GeneFamily	Progestin and adipoQ receptor family	PAQR5 PAQR6	1.43e-03	11	94	2	930
GeneFamily	Fibronectin type III domain containing	MPL PTPRU ASTN2 OSMR USH2A	1.49e-03	160	94	5	555
Coexpression	LIM_MAMMARY_STEM_CELL_DN	HDHD3 KIF1B LARS1 CBLC ARHGEF16 STAT5A TBC1D8 ARFGEF3 TLR3 TMPRSS2 SPDEF ALG8 COASY RBM47	1.99e-08	417	129	14	M2574
Coexpression	LIM_MAMMARY_STEM_CELL_DN	HDHD3 KIF1B LARS1 CBLC ARHGEF16 STAT5A TBC1D8 ARFGEF3 TLR3 TMPRSS2 SPDEF ALG8 COASY RBM47	3.46e-08	436	129	14	MM1326
Coexpression	GSE40493_BCL6_KO_VS_WT_TREG_DN	GALNT14 PLB1 CBLC GDPD2 RSPH6A ALG8 ACSS3	1.88e-06	117	129	7	M9403
Coexpression	CUI_TCF21_TARGETS_2_DN	ERG CEP85L NT5E KIF1B ARHGEF16 ARFGEF3 SLC17A5 PALS1 PARP4 FRY ACKR3 TLR3 OSMR MED23 HEATR5B	2.08e-05	854	129	15	M1533
Coexpression	CUI_TCF21_TARGETS_2_DN	ERG CEP85L NT5E KIF1B ARHGEF16 ARFGEF3 SLC17A5 PALS1 PARP4 FRY ACKR3 TLR3 OSMR MED23 HEATR5B	3.25e-05	888	129	15	MM1018
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	ERG NLRP1 TFIP11 SUPT6H TMEM132A PLOD1 CBX2	5.99e-05	199	129	7	M7254
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP	PTGES2 CTSC CH25H PSME4 NPY4R TLR3 WRAP73	6.18e-05	200	129	7	M4056
Coexpression	GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP	SRC CH25H MED13L FANCM STAT5A ACKR3 PPP1R15B	6.18e-05	200	129	7	M9856
Coexpression	DESCARTES_FETAL_EYE_RETINAL_PROGENITORS_AND_MULLER_GLIA	GABRG3 GDPD2 DNAH11	7.53e-05	17	129	3	M40186
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#1_top-relative-expression-ranked_500	PAQR5 ARHGEF16 CCDC198 TMPRSS2 RBM47	5.86e-06	45	122	5	gudmap_developingKidney_e15.5_Medullary collecting duct_500_k1
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#1_top-relative-expression-ranked_100	CCDC198 TMPRSS2 RBM47	1.52e-05	9	122	3	gudmap_developingKidney_e15.5_Medullary collecting duct_100_k1
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#5_top-relative-expression-ranked_1000	PAQR5 ARHGEF16 CCDC198 TMPRSS2 RBM47 SOWAHB	6.50e-05	119	122	6	gudmap_developingKidney_e15.5_cortic collect duct_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#3_top-relative-expression-ranked_500	CFI CCDC198 TMPRSS2 RBM47	7.30e-05	39	122	4	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#1_top-relative-expression-ranked_200	CCDC198 TMPRSS2 RBM47	9.81e-05	16	122	3	gudmap_developingKidney_e15.5_Medullary collecting duct_200_k1
CoexpressionAtlas	DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_500	ARHGEF16 CCDC198 TMPRSS2 RBM47	1.18e-04	44	122	4	gudmap_developingKidney_e15.5_Proximal Tubules_500_k3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L MFHAS1 PAQR5 ALDH1L1 DNAH14 CCDC198 ASTN2 RBM47	5.74e-09	193	130	9	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L PAQR5 KCP DNAH14 CCDC198 ASTN2 RBM47	1.07e-07	194	130	8	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L MFHAS1 PAQR5 DNAH14 CCDC198 ASTN2 RBM47	1.07e-07	194	130	8	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L PAQR5 KCP DNAH14 CCDC198 ASTN2 RBM47	1.16e-07	196	130	8	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L PAQR5 KCP DNAH14 CCDC198 ASTN2 RBM47	1.16e-07	196	130	8	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRID1 FREM1 ARFGEF3 UNC13C USH2A DNAH9 DNAH11	1.18e-06	184	130	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRID1 FREM1 ARFGEF3 UNC13C USH2A DNAH9 DNAH11	1.18e-06	184	130	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRID1 FREM1 ARFGEF3 UNC13C USH2A DNAH9 DNAH11	1.18e-06	184	130	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 PAQR5 ALDH1L1 DNAH14 CCDC198 ASTN2 RBM47	1.62e-06	193	130	7	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L PAQR5 DNAH14 CCDC198 ASTN2 RBM47	1.74e-06	195	130	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	facs-Spleen-nan-18m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTR7 CH25H GDPD2 NLRP1 KLHL23 CDC6	9.42e-06	166	130	6	8d535fab019356894b4dad3fbdbc4d2ad3e16082
ToppCell	facs-Spleen-nan-18m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTR7 CH25H GDPD2 NLRP1 KLHL23 CDC6	9.42e-06	166	130	6	f56b1c0d6cb5353a16a2598bda905287f16d2c39
ToppCell	facs-Spleen-nan-18m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTR7 CH25H GDPD2 NLRP1 KLHL23 CDC6	9.42e-06	166	130	6	a5074c96c6561273029aceb93402a7e038140f50
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ERG PAQR5 STAT5A USP38 ACKR3 PLOD1	1.15e-05	172	130	6	8a6a2b4c6654bc976e60a02d0e7303a9071ed55f
ToppCell	severe_COVID-19-HSPC\|severe_COVID-19 / disease group, cell group and cell class (v2)	ERG BIRC7 CFI KLHL23 CES3 CBX2	1.23e-05	174	130	6	6d35bacf073537b272ff821e604c899fb9ce6a7c
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEC16B NT5E ALDH1L1 ARFGEF3 RBM47 EVI5L	1.27e-05	175	130	6	96219e58dcb327fd27190be78193e7a0d611e62b
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEC16B NT5E ALDH1L1 ARFGEF3 RBM47 EVI5L	1.27e-05	175	130	6	cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa
ToppCell	droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HTR7 RYR1 TBC1D8 TLR3 PALS2 RBM47	1.27e-05	175	130	6	4655d3daa95e8ffa7d5ee4180de06b2fec361bfb
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 PAQR5 ALDH1L1 CCDC198 ASTN2 PALS2	1.49e-05	180	130	6	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 PAQR5 ALDH1L1 CCDC198 ASTN2 PALS2	1.49e-05	180	130	6	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	GALNT14 KANSL1L SEC16B CCDC198 ASTN2 PALS2	1.69e-05	184	130	6	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	COVID-19-kidney-Mito-rich_PCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 PAQR5 ALDH1L1 CCDC198 ASTN2 G6PC1	1.74e-05	185	130	6	1bbc2ba8a20f72f61981b1301cdd6018cdd9150d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MFHAS1 DNAH14 ASTN2 PALS2 DNAH11	1.80e-05	186	130	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	droplet-Heart-HEART-1m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPL SRC PAQR6 GDF9 RAB38 DNAH11	1.80e-05	186	130	6	fddc6b93f98b10aaf8d4ebc142b46d8213f3129d
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BIRC7 ARFGEF3 TMEM132A ASTN2 UNC13C DNAH11	1.85e-05	187	130	6	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)--\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ERG CH25H CFI ITIH4 OASL	1.87e-05	111	130	5	9ba3590be8862c23b6e2917caed8bdbd9f9c2753
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ERG CH25H CFI ITIH4 OASL	1.87e-05	111	130	5	3e38efb22c47506ef2e2c1e19c79450e11d0ce56
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lcn2_(Lcn2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ERG CH25H CFI ITIH4 OASL	1.87e-05	111	130	5	cd84f2a9102a6eb63226ecde11d4ece54ff99b48
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MFHAS1 DNAH14 CCDC198 ASTN2 PALS2	1.91e-05	188	130	6	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 DNAH14 PARP4 CCDC198 ASTN2 DNAH11	1.91e-05	188	130	6	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 DNAH14 PARP4 CCDC198 ASTN2 DNAH11	1.97e-05	189	130	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	COVID-19-kidney-CNT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 MFHAS1 PAQR5 ALDH1L1 FREM1 CCDC198	2.15e-05	192	130	6	760c6b9628de9693034b00c5025c5c4df94bb2e8
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GALNT14 CBLC ARHGEF16 RYR1 RAB38 MUC4	2.21e-05	193	130	6	7c34abdcb8839b9fb25457a79af6c5e7b9714b21
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L PAQR5 DNAH14 CCDC198 ASTN2	2.28e-05	194	130	6	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	COPD-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	MFHAS1 CTSC NUP88 OSMR PALS2 MUC4	2.41e-05	196	130	6	af96fb94886e9395f3e2cd0a293af29229d017fe
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KANSL1L MFHAS1 CCDC198 ASTN2 RBM47	2.48e-05	197	130	6	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CBLC CEMIP CSF3 TMEM132A OSMR MUC4	2.55e-05	198	130	6	77517df37dc894c78ef1e2b24dd7ba31f928bdb7
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1\|Striatum / BrainAtlas - Mouse McCarroll V32	GDPD2 PAQR6 BIRC7 ALDH1L1 TLR3	2.62e-05	119	130	5	d47880ef1cff036192c43646a04fa8598dd7e1f4
ToppCell	Striatum-Macroglia-ASTROCYTE\|Striatum / BrainAtlas - Mouse McCarroll V32	GDPD2 PAQR6 BIRC7 ALDH1L1 TLR3	2.62e-05	119	130	5	0583387cc4497cf991fa42a81f2f66d9c6b774eb
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPY1R CEP85L ARFGEF3 TMPRSS2 ASTN2 RBM47	2.70e-05	200	130	6	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	Kidney\|World / Skin and Kidney Cells in Lupus Nephritis Patients.	GALNT14 PAQR5 ALDH1L1 CFI CCDC198 RBM47	2.70e-05	200	130	6	1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63
ToppCell	Thalamus-Macroglia-ASTROCYTE\|Thalamus / BrainAtlas - Mouse McCarroll V32	PAQR6 BIRC7 ALDH1L1 FREM1 ACSS3	2.83e-05	121	130	5	c3a4dfd19b7e8654e859df605d55155b530ad009
ToppCell	Thalamus-Macroglia-ASTROCYTE-Gja1\|Thalamus / BrainAtlas - Mouse McCarroll V32	PAQR6 BIRC7 ALDH1L1 FREM1 ACSS3	2.83e-05	121	130	5	c3efd44bd01c12ef8c7ce4cc351af1540b70a63c
ToppCell	Entopeduncular-Macroglia-ASTROCYTE\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GDPD2 PAQR6 BIRC7 ALDH1L1 ACSS3	3.85e-05	129	130	5	c37bdd6c0b2944fbfa064922954ea0e263160e2a
ToppCell	Entopeduncular-Macroglia-ASTROCYTE-Gja1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GDPD2 PAQR6 BIRC7 ALDH1L1 ACSS3	3.85e-05	129	130	5	8648ae59f7aca0f5b4983bdb4a65b03b2ca761e1
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ERG CH25H PAQR5 KCP OASL	4.15e-05	131	130	5	d5bc40cd585582856881081b7130dec3515b4ae0
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-immature_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPY1R CEP85L GEMIN5 ARFGEF3 SLC17A5	4.30e-05	132	130	5	9936078c328b1e1d59f9dfdd69d36926a0cdaf0d
ToppCell	Substantia_nigra-Macroglia-ASTROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GDPD2 BIRC7 ALDH1L1 TLR3 ACSS3	4.62e-05	134	130	5	a632d78890fcc20db81d2cf6b299470706d2e182
ToppCell	Substantia_nigra-Macroglia-ASTROCYTE-Gja1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GDPD2 BIRC7 ALDH1L1 TLR3 ACSS3	4.62e-05	134	130	5	8be2db71d9d29f9a57a64efdc89cf8c3e32b363b
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GABRG3 HDHD3 PLB1 HTR7 NLRP1	6.94e-05	146	130	5	b76110b159acd27a2c8d6a9f98336608ace1ec12
ToppCell	droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CFI ITIH4 CES3 G6PC1	7.17e-05	147	130	5	00619115b9a1ec2b967c2992043b41974ece63c4
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_TIP\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BRIP1 ITIH4 CEMIP CDC6 ACSS3	7.64e-05	149	130	5	3980fa4f1986a2f164a1826ea043fb71f1d756cd
ToppCell	droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CFI ITIH4 CES3 G6PC1	8.14e-05	151	130	5	cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4
ToppCell	droplet-Liver-nan-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CFI ITIH4 CES3 G6PC1	8.14e-05	151	130	5	7758cfbe8dca849c90bd6e8bc63310e53beeb8fd
ToppCell	droplet-Liver-nan-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CFI ITIH4 CES3 G6PC1	8.14e-05	151	130	5	b4a0546c1573b4b2290890307f2a5daf3a7cbb37
ToppCell	droplet-Liver-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CFI ITIH4 CES3 G6PC1	8.40e-05	152	130	5	1febeeb7376e34b9f86c81b2cb1314ee12408864
ToppCell	droplet-Liver-nan-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CFI ITIH4 CES3 G6PC1	8.40e-05	152	130	5	faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1
ToppCell	droplet-Liver-nan-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CFI ITIH4 CES3 G6PC1	9.78e-05	157	130	5	b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	GABRG3 CYP21A2 NALCN TMEM132A CBX2	1.01e-04	158	130	5	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CH25H KCP OASL CBX2	1.02e-04	83	130	4	3aa95bf2d8ac37e648037faf3d54ebb243a4fde1
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CH25H KCP OASL CBX2	1.02e-04	83	130	4	70804dd63221dd5ed26068ec1b50f11875abbc50
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CH25H KCP OASL CBX2	1.02e-04	83	130	4	c1818411438f53aec76afead5c8caab701b95d39
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	CH25H KCP OASL CBX2	1.02e-04	83	130	4	1e7af8aaa20b4c2a77cf2f330113db0faa9d483c
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	GABRG3 TMEM132B RYR1 USH2A DNAH9	1.04e-04	159	130	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KNTC1 BRIP1 CTSC CH25H CDC6	1.04e-04	159	130	5	c0e55f25271f788c08fa4b95186501fc27b2ec39
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 KCP FREM1 USH2A DNAH9	1.07e-04	160	130	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 KCP FREM1 USH2A DNAH9	1.07e-04	160	130	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BRIP1 KCP CFI STAT5A CBX2	1.10e-04	161	130	5	a7e74bc80ac11250e353e5614b19c05793fc2e95
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTSC GDF9 CEMIP HPS1 RBM47	1.13e-04	162	130	5	71d7849108a1b59beff40e46000172c45a2f5439
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CH25H KCP CFI G6PC1	1.23e-04	87	130	4	cc89f4176b70d4eb5b5bf0ff2319b5f1f9e292c0
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CH25H KCP CFI G6PC1	1.23e-04	87	130	4	4274e04fa4aca85c2cefd8c5e03d0fa4a4f15536
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CH25H KCP CFI G6PC1	1.23e-04	87	130	4	54cbdf80aae3595eaace20c7cbac763282558213
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)--\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CH25H KCP CFI G6PC1	1.23e-04	87	130	4	8b1a0bd5d6af32afaca19e9c69f86530bbaa309d
ToppCell	3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ALDH1L1 ARHGEF16 SPDEF MUC4 SOWAHB	1.34e-04	168	130	5	2163e6774eb7a3d010422e4d59be5e45b4158329
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NALCN UNC13C USH2A DNAH9 DNAH11	1.38e-04	169	130	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 GDF9 ZNF221 G6PC1 CBX2	1.42e-04	170	130	5	d70aaa0f4e5034bb9f61b832b5f9123870936d3c
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HTR7 RYR1 TBC1D8 TLR3 PALS2	1.42e-04	170	130	5	bf589c4297ccc90e5f51e3d0fcc229548af4fcef
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALDH1L1 CSF3 SBF1 CD101 OASL	1.42e-04	170	130	5	f3d5678669dcaed1836014cea543758b7ccc6b46
ToppCell	facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial-new-cluster\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPL HDHD3 ALDH1L1 CFI RAB38	1.50e-04	172	130	5	2fcc6278ead890019a6505fb4fcb518751262dda
ToppCell	mild-Others-CD34+_GATA2+_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MPL ERG FREM1 CES3 CBX2	1.50e-04	172	130	5	379f6f271e653d5e404851e51a189bd582bb0f43
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-AT2\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CTSC GDPD2 ARHGEF16 RBM47 MUC4	1.54e-04	173	130	5	f6e36ea98a9c669ff393d141455aaecef083f738
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTR7 PAQR5 TLR3 ALG8 DNAH11	1.54e-04	173	130	5	15af4a0f7516dbf5c93ba66a19aca073ebe30d04
ToppCell	droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HTR7 RYR1 TBC1D8 PALS2 RBM47	1.67e-04	176	130	5	7d1e2627d7ec5ddd6c87c55d2a6879255b76949e
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TBC1D8 ARFGEF3 TMPRSS2 OSMR MUC4	1.67e-04	176	130	5	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	GALNT14 NT5E ARFGEF3 PALS2 MUC4	1.71e-04	177	130	5	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	COVID-19-kidney-PCT-S1/S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 ALDH1L1 CCDC198 ASTN2 G6PC1	1.76e-04	178	130	5	23a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1B SRC PEX1 TBC1D8 RBM47	1.85e-04	180	130	5	be10fe5bf7c3a671c42704ce7dd8226ab6896794
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1B SRC PEX1 TBC1D8 RBM47	1.85e-04	180	130	5	3b747a517ce75ef2ff09011c037dad7b01ed3e03
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	MFHAS1 ARFGEF3 TMPRSS2 OSMR MUC4	1.90e-04	181	130	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	COVID-19-kidney-CD-IC-B\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MFHAS1 FREM1 TMPRSS2 ASTN2 UNC13C	1.95e-04	182	130	5	ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 PAQR5 ALDH1L1 CCDC198 ASTN2	1.95e-04	182	130	5	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 ALDH1L1 CCDC198 ASTN2 PALS2	2.00e-04	183	130	5	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-club_cell-club_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLB1 CBLC ARHGEF16 ARFGEF3 ACSS3	2.05e-04	184	130	5	204d16c48f822c98dc4118ac97a4f99f7e1163c8
ToppCell	droplet-Lung-21m-Epithelial-airway_epithelial-club_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLB1 CBLC ARHGEF16 ARFGEF3 ACSS3	2.05e-04	184	130	5	9365cdc52a2419e3f27e1c1c9310fa707d1e506b
ToppCell	droplet-Lung-nan-21m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 CBLC ARHGEF16 ARFGEF3 ACSS3	2.05e-04	184	130	5	7cc3b9bba1f600b40b02fe2456b5d007dbf9fa37
ToppCell	droplet-Lung-nan-21m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 CBLC ARHGEF16 ARFGEF3 ACSS3	2.05e-04	184	130	5	53b71c4ac86dc5e42763b8f64fbc917177531017
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAQR5 ARFGEF3 ASTN2 UNC13C RBM47	2.10e-04	185	130	5	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HTR7 RYR1 TBC1D8 TLR3 PALS2	2.10e-04	185	130	5	ed7b26bdebfd0df2b4f5020a855a052d94ae7219
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PTGES2 DNAH14 ARFGEF3 OSMR RBM47	2.16e-04	186	130	5	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 MFHAS1 DNAH14 ASTN2 PALS2	2.21e-04	187	130	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	PPFIA1 SRC INTS1 PAQR6 PTPRU ARHGEF16 TBC1D8 TMEM132A ASTN2	2.01e-06	200	128	9	3405_DN
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A	KANSL1L SRC PAQR5 BIRC7 ALDH1L1 OASL TMPRSS2 OSMR	1.14e-05	188	128	8	5490_UP
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; HL60; HG-U133A	MARS1 LARS1 OPA1 DALRD3 PTPA ATM HERC1 RBM47	1.38e-05	193	128	8	1768_DN
Drug	Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A	CYP1A2 HDHD3 PTGES2 TFIP11 SBF1 SUPT6H TMEM132A ATM	1.49e-05	195	128	8	6310_DN
Drug	Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A	ROCK2 HDHD3 PTGES2 BRIP1 MARS1 NUP98 PEX1 OASL	1.55e-05	196	128	8	2113_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; PC3; HT_HG-U133A	PTGES2 MARS1 DALRD3 SLC17A5 SBF1 SUPT6H HPS1 OSMR	1.55e-05	196	128	8	2089_DN
Drug	Natamycin [7681-93-8]; Up 200; 6uM; HL60; HT_HG-U133A	NLRP1 BIRC7 CFI ZZEF1 RYR1 NPY4R SPDEF ASTN2	1.61e-05	197	128	8	6126_UP
Drug	Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ROCK2 NUP98 SLC17A5 CRELD1 PSME4 HPS1 CES3 ATM	1.67e-05	198	128	8	5545_DN
Drug	CH3Hg	NT5E MARS1 NLRP1 SUPT6H G6PC1	2.21e-05	60	128	5	CID000007905
Disease	Infantile liver failure	MARS1 LARS1	1.84e-05	2	127	2	cv:C5681094
Disease	Leukemia, Myelocytic, Acute	BRIP1 ERG NUP98 CBLC FANCM CSF3	1.07e-04	173	127	6	C0023467
Disease	heel bone mineral density, urate measurement	DNAH14 TBC1D8 NPY4R2 NPY4R ASTN2 PALS2	1.41e-04	182	127	6	EFO_0004531, EFO_0009270
Disease	quality of life during menstruation measurement	TMEM245 ASTN2	1.82e-04	5	127	2	EFO_0009366
Disease	Pancytopenia	BRIP1 FANCM CSF3	1.88e-04	26	127	3	C0030312
Disease	thrombocytopenia (is_implicated_in)	MPL BRIP1 SRC	2.11e-04	27	127	3	DOID:1588 (is_implicated_in)
Disease	L-arginine measurement	CYP21A2 MED23 PRMT7	2.11e-04	27	127	3	EFO_0006524
Disease	childhood absence epilepsy (implicated_via_orthology)	NPY1R HTR7	2.73e-04	6	127	2	DOID:1825 (implicated_via_orthology)
Disease	behavioural disinhibition measurement	CYP21A2 UNC13C DNAH9 DNAH11	3.14e-04	75	127	4	EFO_0006946
Disease	non-small cell lung carcinoma	CYP1A2 CYP21A2 NLRP1 NALCN	3.14e-04	75	127	4	EFO_0003060
Disease	bitter non-alcoholic beverage consumption measurement	CYP1A2 SEC16B HPS1	3.53e-04	32	127	3	EFO_0010093
Disease	myeloid leukemia (is_marker_for)	MPL CSF3	3.81e-04	7	127	2	DOID:8692 (is_marker_for)
Disease	serine:glycine ratio	ALDH1L1 PTPRU	3.81e-04	7	127	2	EFO_0021777
Disease	Fanconi anemia (implicated_via_orthology)	BRIP1 FANCM	5.06e-04	8	127	2	DOID:13636 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	SEC16B PLB1 BRIP1 CYP21A2 NLRP1 TBC1D8 C1orf220 OASL TMPRSS2 ASTN2 G6PC1 ACSS3	6.00e-04	914	127	12	EFO_0004532
Disease	overall survival	CTSC OSMR	6.49e-04	9	127	2	EFO_0000638
Disease	Melancholia	NPY1R HTR7 CSF3	7.37e-04	41	127	3	C0025193
Disease	Depression, Neurotic	NPY1R HTR7 CSF3	7.37e-04	41	127	3	C0282126
Disease	Charcot-Marie-Tooth disease	MARS1 KIF1B SBF1	7.91e-04	42	127	3	cv:C0007959
Disease	Depressive Syndrome	NPY1R HTR7 CSF3	7.91e-04	42	127	3	C0086133
Disease	quality of life during menstruation measurement, aggressive behavior	GABRG3 TMEM132B	8.09e-04	10	127	2	EFO_0003015, EFO_0009366
Disease	Malignant Head and Neck Neoplasm	BRIP1 FANCM CSF3	9.06e-04	44	127	3	C0278996
Disease	Endogenous depression	NPY1R HTR7 CSF3	1.03e-03	46	127	3	C0011573
Disease	urinary albumin to creatinine ratio	GABRG3 CYP1A2 CTSC CYP21A2 UNC13C	1.09e-03	179	127	5	EFO_0007778
Disease	sialate O-acetylesterase measurement	RAB38 HPS1	1.18e-03	12	127	2	EFO_0803073
Disease	creatinine measurement	CYP1A2 BRIP1 CYP21A2 ALDH1L1 RYR1 CEMIP TBC1D8 FRY ASTN2 MED23 PRMT7 RBM47	1.25e-03	995	127	12	EFO_0004518
Disease	heart failure	BRIP1 CEP85L CH25H RSPH6A HEATR5B	1.26e-03	185	127	5	EFO_0003144
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	KIF1B ITIH4	1.39e-03	13	127	2	DOID:332 (biomarker_via_orthology)
Disease	colon carcinoma (is_marker_for)	SRC TLR3	1.39e-03	13	127	2	DOID:1520 (is_marker_for)
Disease	urate measurement, bone density	PLB1 GRID1 DNAH14 FREM1 ALG8 USH2A DNAH9 G6PC1 DNAH11	1.47e-03	619	127	9	EFO_0003923, EFO_0004531
Disease	interleukin 1 receptor antagonist measurement	CSF3 ASTN2 DNAH11	1.56e-03	53	127	3	EFO_0004754
Disease	Depressive disorder	NPY1R HTR7 GRID1 CSF3 ALG8 GABPA	1.61e-03	289	127	6	C0011581
Disease	N-acetylglycine measurement	CYP21A2 ALDH1L1	1.62e-03	14	127	2	EFO_0021002
Disease	diffuse plaque measurement	GALNT14 NPY1R CH25H GRID1 ALDH1L1 TMEM132B DNAH14 ARFGEF3 SPDEF DNAH11	1.66e-03	758	127	10	EFO_0010699
Disease	leukemia	BRIP1 ERG ATM	1.73e-03	55	127	3	C0023418
Disease	platelet storage pool deficiency (implicated_via_orthology)	RAB38 HPS1	1.86e-03	15	127	2	DOID:2223 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease type 2	MARS1 KIF1B	2.40e-03	17	127	2	cv:C0270914
Disease	Bone marrow hypocellularity	BRIP1 FANCM	2.69e-03	18	127	2	C1855710
Disease	caudal middle frontal gyrus volume measurement	FRY ASTN2	2.69e-03	18	127	2	EFO_0010290
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	SEC16B MFHAS1 CBLC SPG11 SPDEF	2.95e-03	225	127	5	EFO_0008317, EFO_0020947
Disease	Chronic myeloproliferative disorder	MPL CDC6	3.00e-03	19	127	2	C1292778
Disease	MYELODYSPLASTIC SYNDROME	MPL BRIP1 FANCM	3.05e-03	67	127	3	C3463824
Disease	body weight	KNTC1 GABRG3 SEC16B CYP21A2 NUP88 CBLC GRID1 ZZEF1 DNAH14 CRELD1 SPDEF ASTN2 PRMT7	3.12e-03	1261	127	13	EFO_0004338
Disease	maximal midexpiratory flow rate	GALNT14 BRIP1	3.32e-03	20	127	2	EFO_0004313
Disease	vitamin D measurement	PLB1 HTR7 CYP21A2 GRID1 MED23 DNAH11	3.41e-03	336	127	6	EFO_0004631
Disease	Left Ventricle Remodeling	ROCK2 OPA1	3.66e-03	21	127	2	C0600520
Disease	Ventricular Remodeling	ROCK2 OPA1	3.66e-03	21	127	2	C0600519
Disease	BREAST CANCER	BRIP1 ATM	3.66e-03	21	127	2	114480
Disease	Neutropenia	NUP98 CSF3	3.66e-03	21	127	2	C0027947
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	BIRC7 RYR1 ATM MUC4	3.90e-03	148	127	4	C0279702
Disease	Alzheimer disease, polygenic risk score	SRC CBLC SPG11 RSPH6A ZZEF1 DNAH14 TMEM245 FAM20B	3.93e-03	586	127	8	EFO_0030082, MONDO_0004975
Disease	anxiety disorder (implicated_via_orthology)	NPY1R HTR7	4.01e-03	22	127	2	DOID:2030 (implicated_via_orthology)
Disease	triacylglycerol 58:9 measurement	PTGES2 CYP21A2	4.01e-03	22	127	2	EFO_0010443
Disease	grip strength measurement	KNTC1 SEC16B PTGES2 KIF1B GRID1 PSME4	4.15e-03	350	127	6	EFO_0006941

Protein segments in the cluster

Peptide	Gene	Start	Entry
HLEEDTWILWGRIAN	EVI5L	81	Q96CN4
QIWTTVVDWIHPDLK	CFI	391	P05156
WPTLLKNWQLLAVNH	CBLC	221	Q9ULV8
PTLWSTDHVRQWLEW	ERG	131	P11308
WIVALTHSERQWQGL	ARHGEF16	611	Q5VV41
PVSWVAHATIQDFWD	CLDN25	136	C9JDP6
TAIDWFHAWPQEALV	DNAH11	3006	Q96DT5
VQETHSQLLGSWDPW	BIRC7	166	Q96CA5
RWQEAASQPALWHTV	FBXL6	146	Q8N531
HWDQTAPAELAIWLI	CEMIP	1056	Q8WUJ3
ISLVHWRQQWLENGT	ASTN2	156	O75129
SWIEVTFKNPLVWVH	ITIH4	781	Q14624
LWGHQIAVDWAEPEI	RBM47	221	A0AV96
WNQVLHWSWESELPL	OSMR	91	Q99650
LHWDPETVVRLQLWD	RAB38	51	P57729
QWQVNHDPELWEDPS	CYP1A2	411	P05177
SRQWWLDVVLQTFHL	HDHD3	71	Q9BSH5
TNETLNIWTHLLPFW	PAQR5	46	Q9NXK6
TLRAWQEKNHPWLEL	POLDIP2	216	Q9Y2S7
EGWHVQRPWQLAQEL	MUC4	4631	Q99102
VESWWFHKQQEAPDL	CRELD1	116	Q96HD1
PEAQIVKHWSLTWTL	NUP98	1261	P52948
LPSLNQSQETKSLWW	KANSL1L	901	A0AUZ9
TWENIQHVQGPLTWQ	MED13L	1346	Q71F56
HASLPNIWTAWQAIT	MFHAS1	946	Q9Y4C4
QIAAIQRDAVWWLHT	INTS1	581	Q8N201
QRDAVWWLHTVVPSI	INTS1	586	Q8N201
VLWLPLHVFNSLEDW	NPY4R	276	P50391
PIQWSTDQVLHWVVW	GABPA	186	Q06546
EVPWTQHEFELAQWA	KIF1B	736	O60333
TGIHQLSLSEWRLWQ	FANCM	726	Q8IYD8
WRLWQDHPLPTHQVD	FANCM	736	Q8IYD8
VDIQPHWVSALAWPE	HERC1	3521	Q15751
WSHWSIQIVDVIPFL	CYP21A2	201	P08686
VWDQFLGEINPQHSW	NLRP1	1131	Q9C000
ATPQILELKWSHIEW	FREM1	1731	Q5H8C1
ENSPEHWLQNDWHTK	MED23	906	Q9ULK4
WVRQAATLNHIDEVW	DUSP13	36	Q9UII6
DMNHEWIGNEWLPSL	PPFIA1	961	Q13136
VWNWPSLHVEEFLLT	KNTC1	286	P50748
VGLDIQWQQEWHSLR	GDPD2	136	Q9HCC8
TSWQLVLATLQHLVW	MON2	696	Q7Z3U7
IVCIQHWQDAVPWTE	PARP4	1561	Q9UKK3
HWQDAVPWTELLSLQ	PARP4	1566	Q9UKK3
TNETVNIWTHFLPTW	PAQR6	46	Q6TCH4
LHNDLWEVFSNPEDW	PLOD1	516	Q02809
VQEHVVWSTPQFWEA	SBF1	671	O95248
DSFVAQWLQPHREWK	OASL	16	Q15646
RQWHQAELAVSTFWP	PTPRU	141	Q92729
ERWLSTGLWHNLELV	BRIP1	706	Q9BX63
WSLHFQWEQLSPEQK	GALNT14	251	Q96FL9
GDILHVISQEDPNWW	PALS1	376	Q8N3R9
WLPLTIFNTVFDWNH	NPY1R	276	P25929
VTPKHWEEILQQSLW	OPA1	611	O60313
IVNREDPNWWQASHV	PALS2	251	Q9NZW5
DINLWIPLSENHDIW	ATM	1791	Q13315
SWWHIPRDQTQPEFV	CD101	446	Q93033
NSWAPILHAVALWLN	HEATR5B	1526	Q9P2D3
LSEVHIWDPLTNVWI	KLHL23	286	Q8NBE8
WSSKHNSWEPEENIL	CBX2	36	Q14781
AHWITTPNQLLRIWN	GABRG3	141	Q99928
WSWNKLFPIHVQTSL	PRMT7	191	Q9NVM4
AQRWCEQPEWVHIDT	G6PC1	241	P35575
LLSVQPVSNADWVWL	ARFGEF3	1886	Q5TH69
QKILHLPTSWDWRNV	CTSC	226	P53634
LPTSWDWRNVHGINF	CTSC	231	P53634
TIPVWVVSLVQHNQW	ACKR3	96	P25106
AWLPANESLWQATTV	CEP85L	31	Q5SZL2
FEWPWLSNSHLVLIG	CDC6	301	Q99741
IPENHNFDWQWIILD	DNAH14	1561	Q0VDD8
QLLLWHSALWTVQEA	CSF3	16	P09919
LELWWNSNRCHQETP	GRID1	851	Q9ULK0
SVLAELQEALWHWPE	DALRD3	246	Q5D0E6
SFSQLKWDNWIVAPH	GDF9	361	O60383
IHAWETTPWRNINVE	DNAH9	1316	Q9NYC9
PLTHNVDLQWLVEWN	FRY	811	Q5TBA9
FWSETLPSKIQQWHQ	CES3	546	Q6UWW8
QRVQLWEHFQSLLWT	HPS1	141	Q92902
WLHEQEAQGQLLWDS	CCDC198	246	Q9NVL8
ISWVLQHQQLLASEW	C1orf220	41	Q5T0J3
FLLWIWLVSDTPQKH	SLC17A5	241	Q9NRA2
NIHELWALTRIEQGW	RYR1	876	P21817
AIEVVWSHQPAFLSW	PEX1	46	O43933
QPLWDHLRSWEALLQ	CH25H	21	O95992
SEWHRAIFLPQAWLA	FOCAD	881	Q5VW36
NFQSWQHWLSLPLSL	OR56A1	26	Q8NGH5
AQLLWSPWSPLDQEE	INCA1	186	Q0VD86
GELWQTWLPNHVVFL	NUP88	11	Q99567
ESLNRTTQWEWFHPK	RSPH6A	241	Q9H0K4
PWAQATSAHSVLLNW	USH2A	3971	O75445
LQIVNNTEGDWWLAH	SRC	111	P12931
VDWLIGNHSDELTPW	TRMT44	416	Q8IYL2
QPHNWVWLGTDQEEL	TMEM132A	891	Q24JP5
HSHDWVWLGNEVELL	TMEM132B	941	Q14DG7
DPVWNETLIWHLWNR	FER1L5	41	A0AVI2
ETLIWHLWNRPLEND	FER1L5	46	A0AVI2
THLPWDEQWLIESLS	LARS1	581	Q9P2J5
AGNSQEQWHPLREWL	KCP	46	Q6ZWJ8
LQRKIHSNSPWWLNV	SHPRH	1131	Q149N8
LAWFILHSNSWDPQQ	MT-ND5	186	P03915
QWADDWLVHLISPNV	PTGES2	236	Q9H7Z7
GLVQVWSLEQPEWHC	WRAP73	71	Q9P2S5
PRLQDSTTLAWHLWN	PLB1	296	Q6P1J6
VTSPLDWLEEGIHWQ	PPP1R15B	136	Q5SWA1
QVWTLFWEDPQLALH	SOWAHB	611	A6NEL2
QWIESQPWDAIDLDN	STAT5A	36	P42229
WPAAGAWELTILHTN	NT5E	21	P21589
VWVLQSPDHHNWLAD	HTR7	451	P34969
RNWLAITHSLPISQW	ALG8	41	Q9BVK2
INWDQPAEAIHNWIR	ALDH1L1	211	O75891
SKNVFRVPVLDHWWQ	ACSS3	436	Q9H6R3
WEPHITQRQVEKAWA	COASY	536	Q13057
PELHINDLWRVWQWD	SUPT6H	386	Q7KZ85
EPDSWHWLLVEAVKQ	SPG11	1451	Q96JI7
AWPWQVSLHVQNVHV	TMPRSS2	266	O15393
WFVNWINETHTNIPE	TLR3	656	O15455
SQLSLHEDLSPWKEW	UNC13C	646	Q8NB66
HSNQLWNISAVPSWS	PTPA	306	Q15257
SPSNVQKWLLWTEHQ	SPDEF	151	O95238
ATLEEINQHWDWLEQ	TBC1D8	81	O95759
QGVWLLTEVDHWNNE	TPRG1L	91	Q5T0D9
LDHTLQSPWEIAAQW	FAM20B	56	O75063
VKERLWLTLHWPSNQ	GEMIN5	281	Q8TEQ6
VLWLPLHVFNSLEDW	NPY4R2	276	P0DQD5
NDQWHWDNIRETAAP	ROCK2	356	O75116
LELEWQHPSSWAAQE	MPL	406	P40238
TDHAPLAIAQVWLWV	UNQ9370/PRO34162	31	Q6UXP9
QLWENHQSWIPRSEH	nan	291	Q6ZUG5
DLWNLGIQWHVPSSE	PSME4	761	Q14997
ANLHDWDCIVQTWPA	PSME4	1041	Q14997
DWLSWPLAQHVDTWV	USP38	276	Q8NB14
QGDVALHLEIVQWQW	TAS1R2	441	Q8TE23
QWGDWRPHLAVILSN	SEC16B	521	Q96JE7
ETLANHPEWANWLPE	TMEM245	501	Q9H330
HPEWANWLPEAQVVQ	TMEM245	506	Q9H330
PHEEWSCQQIWEQIA	ZNF221	116	Q9UK13
VETWQQEQPVVLHTW	ZZEF1	1081	O43149
TNQWLEWEATELQPA	MARS1	81	P56192
WVHIIPVWILDNILD	TFIP11	511	Q9UBB9
NVLIWPTDGSHWLNI	UGT2A2	31	P0DTE5
DNADILWINKPWVHS	NALCN	26	Q8IZF0